» Articles » PMID: 17553227

Human Alveolar Echinococcosis After Fox Population Increase, Switzerland

Abstract

We analyzed databases spanning 50 years, which included retrospective alveolar echinococcosis (AE) case finding studies and databases of the 3 major centers for treatment of AE in Switzerland. A total of 494 cases were recorded. Annual incidence of AE per 100,000 population increased from 0.12-0.15 during 1956-1992 and a mean of 0.10 during 1993-2000 to a mean of 0.26 during 2001-2005. Because the clinical stage of the disease did not change between observation periods, this increase cannot be explained by improved diagnosis. Swiss hunting statistics suggested that the fox population increased 4-fold from 1980 through 1995 and has persisted at these higher levels. Because the period between infection and development of clinical disease is long, the increase in the fox population and high Echinococcus multilocularis prevalence rates in foxes in rural and urban areas may have resulted in an emerging epidemic of AE 10-15 years later.

Citing Articles

Echinococcus granulosus sensu lato control measures: a specific focus on vaccines for both definitive and intermediate hosts.

Borhani M, Fathi S, Harandi M, Casulli A, Ding J, Liu M Parasit Vectors. 2024; 17(1):533.

PMID: 39716337 PMC: 11665232. DOI: 10.1186/s13071-024-06581-2.


Pictorial review of hepatic echinococcosis: Ultrasound imaging and differential diagnosis.

Tao Y, Wang Y, Wang J, Long S, Seyler B, Zhong X World J Gastroenterol. 2024; 30(37):4115-4131.

PMID: 39474399 PMC: 11514533. DOI: 10.3748/wjg.v30.i37.4115.


Enhancing the therapeutic potential of P29 protein-targeted monoclonal antibodies in the management of alveolar echinococcosis through CDC-mediated mechanisms.

Zhang C, Li T, Hou S, Tang J, Wen R, Wang C PLoS Pathog. 2024; 20(8):e1012479.

PMID: 39178325 PMC: 11376570. DOI: 10.1371/journal.ppat.1012479.


Case Report: Disseminated hydatid cyst: Unusual presentation and therapeutic challenges.

Mohamed Babiker A, Abdelrahman A, Abdalkarim A, Algaly G, Sanosi A, Abdalla E F1000Res. 2024; 12:1492.

PMID: 39050979 PMC: 11267145. DOI: 10.12688/f1000research.142072.2.


Human alveolar echinococcosis in Slovakia: Epidemiology and genetic diversity of Echinococcus multilocularis, 2000-2023.

Antolova D, Snabel V, Jarosova J, Cavallero S, DAmelio S, Syrota Y PLoS Negl Trop Dis. 2024; 18(1):e0011876.

PMID: 38198452 PMC: 10805277. DOI: 10.1371/journal.pntd.0011876.


References
1.
McManus D, Zhang W, Li J, Bartley P . Echinococcosis. Lancet. 2003; 362(9392):1295-304. DOI: 10.1016/S0140-6736(03)14573-4. View

2.
Kern P, Bardonnet K, Renner E, Auer H, Pawlowski Z, Ammann R . European echinococcosis registry: human alveolar echinococcosis, Europe, 1982-2000. Emerg Infect Dis. 2003; 9(3):343-9. PMC: 2958541. DOI: 10.3201/eid0903.020341. View

3.
Deplazes P, Hegglin D, Gloor S, Romig T . Wilderness in the city: the urbanization of Echinococcus multilocularis. Trends Parasitol. 2004; 20(2):77-84. DOI: 10.1016/j.pt.2003.11.011. View

4.
Drolshammer I, WIESMANN E, Eckert J . [Human echinococcosis in Switzerland during the years 1956-1969]. Schweiz Med Wochenschr. 1973; 103(40):1386-92 contd. View

5.
RAUSCH R, Wilson J, Schantz P . A programme to reduce the risk of infection by Echinococcus multilocularis: the use of praziquantel to control the cestode in a village in the hyperendemic region of Alaska. Ann Trop Med Parasitol. 1990; 84(3):239-50. DOI: 10.1080/00034983.1990.11812463. View